Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

‘Nanomeds’: Tiny Sensors May Soon Monitor Patients’ Medicines from Inside

Washington, DC, December 15, 2014 ― Frank Browning reports on Kaiser Family Health about a medical innovation called “nanomeds” that are miniscule sensors embedded in a placebo pill that the patient swallow.

Browning reports that these “ingestibles” — which are the size of BBs and, actually, not digested by the body — are switched on by contact with saliva and/or gastric juices.  The signal then is picked up by another sensor which looks like a Band-Aid and is worn on your chest.

This system records medicine intake as well as other measures, such as heart rate. The information shows up on your smartphone or tablet, via Bluetooth and can automatically go to your doctors, family members or caregivers, with your permission.

“We are entering the commercial era of the Internet of Things (IoT) — your car, your clothes and increasingly your personal care products are going to be connected,” says Andrew Thompson, CEO of Proteus Digital Health, which makes these “ingestibles.”

Only about 50 percent of patients take their medications as prescribed.

Also, according to the Centers for Disease Control and Prevention (CDC), in 2010 almost 40 percent of adults older than 65 were taking five or more prescriptions a day.

For Mr. Browning’s complete story, click here.